Research
Energy balance
There is a significant and growing public interest in Ozempic and related GLP-1 agonists.
Healthcare providers should be prepared for increased inquiries about these medications.
StrongSupportsmedium confidence
This study demonstrates a significant and growing public interest in Ozempic and related GLP-1 agonists.
Why this rating
The claim is supported by data analysis over a significant time frame.
Source
Public Interest in the Off-Label Use of Glucagon-like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis
Sabrina H. Han et al. · Aesthetic Surgery Journal · 2023
DOI 10.1093/asj/sjad211
otherCited 180×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →